Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
69.14
-1.09 (-1.55%)
May 13, 2025, 4:00 PM - Market closed
Haemonetics Revenue
In the fiscal year ending March 29, 2025, Haemonetics had annual revenue of $1.36B with 3.95% growth. Haemonetics had revenue of $330.60M in the quarter ending March 29, 2025, a decrease of -3.70%.
Revenue (ttm)
$1.36B
Revenue Growth
+3.95%
P/S Ratio
2.56
Revenue / Employee
$372,115
Employees
3,657
Market Cap
3.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 29, 2025 | 1.36B | 51.77M | 3.95% |
| Mar 30, 2024 | 1.31B | 140.40M | 12.01% |
| Apr 1, 2023 | 1.17B | 175.46M | 17.67% |
| Apr 2, 2022 | 993.20M | 122.73M | 14.10% |
| Apr 3, 2021 | 870.46M | -118.02M | -11.94% |
| Mar 28, 2020 | Pro | Pro | Pro |
| Mar 30, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Apr 1, 2017 | Pro | Pro | Pro |
| Apr 2, 2016 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
HAE News
- 3 days ago - Haemonetics Corporation (HAE) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website - PRNewsWire
- 6 weeks ago - Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025 - PRNewsWire
- 2 months ago - Haemonetics Announces Executive Leadership Updates - PRNewsWire
- 2 months ago - Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference - PRNewsWire
- 3 months ago - Haemonetics Corporation (HAE) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website - PRNewsWire
- 4 months ago - Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A - PRNewsWire